Search

Ryan N. Henderson

Examiner (ID: 2057, Phone: (571)270-1430 , Office: P/3779 )

Most Active Art Unit
3795
Art Unit(s)
3739, 3795, 3779
Total Applications
931
Issued Applications
516
Pending Applications
102
Abandoned Applications
329

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 903748 [patent_doc_number] => 07335761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Avian gene expression controlling regions' [patent_app_type] => utility [patent_app_number] => 11/047184 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 43 [patent_no_of_words] => 30540 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335761.pdf [firstpage_image] =>[orig_patent_app_number] => 11047184 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/047184
Avian gene expression controlling regions Jan 30, 2005 Issued
Array ( [id] => 5210043 [patent_doc_number] => 20070248627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines' [patent_app_type] => utility [patent_app_number] => 10/585884 [patent_app_country] => US [patent_app_date] => 2005-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17305 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248627.pdf [firstpage_image] =>[orig_patent_app_number] => 10585884 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/585884
Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines Jan 11, 2005 Issued
Array ( [id] => 5696275 [patent_doc_number] => 20060156422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Methods and compositions for the generation of antibodies' [patent_app_type] => utility [patent_app_number] => 11/032668 [patent_app_country] => US [patent_app_date] => 2005-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28424 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20060156422.pdf [firstpage_image] =>[orig_patent_app_number] => 11032668 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/032668
Methods and compositions for the generation of antibodies Jan 9, 2005 Abandoned
Array ( [id] => 6941353 [patent_doc_number] => 20050114916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Production of proteins in eggs' [patent_app_type] => utility [patent_app_number] => 11/024216 [patent_app_country] => US [patent_app_date] => 2004-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8755 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20050114916.pdf [firstpage_image] =>[orig_patent_app_number] => 11024216 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/024216
Production of proteins in eggs Dec 26, 2004 Abandoned
Array ( [id] => 7978183 [patent_doc_number] => 08071839 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Transgenic mouse comprising a polynucleotide encoding human or humanized C5aR and methods of production and use' [patent_app_type] => utility [patent_app_number] => 10/584480 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 21862 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071839.pdf [firstpage_image] =>[orig_patent_app_number] => 10584480 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584480
Transgenic mouse comprising a polynucleotide encoding human or humanized C5aR and methods of production and use Dec 23, 2004 Issued
Array ( [id] => 5103028 [patent_doc_number] => 20070186290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 10/596627 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 25504 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20070186290.pdf [firstpage_image] =>[orig_patent_app_number] => 10596627 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/596627
Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases Dec 16, 2004 Abandoned
Array ( [id] => 4932858 [patent_doc_number] => 20080003633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Methods for Relieving Neuropathic Pain by Modulating Alpha1G T-Type Calcium Channels and Mice Lacking Alpha 1G T-Type Calcium Channels' [patent_app_type] => utility [patent_app_number] => 11/721652 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3148 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20080003633.pdf [firstpage_image] =>[orig_patent_app_number] => 11721652 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/721652
Methods for Relieving Neuropathic Pain by Modulating Alpha1G T-Type Calcium Channels and Mice Lacking Alpha 1G T-Type Calcium Channels Dec 12, 2004 Abandoned
Array ( [id] => 6905163 [patent_doc_number] => 20050100558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Heterologous boosting immunizations' [patent_app_type] => utility [patent_app_number] => 11/007115 [patent_app_country] => US [patent_app_date] => 2004-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8708 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100558.pdf [firstpage_image] =>[orig_patent_app_number] => 11007115 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/007115
Heterologous boosting immunizations Dec 7, 2004 Abandoned
Array ( [id] => 4669759 [patent_doc_number] => 20080044819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Genetic Reference Materials' [patent_app_type] => utility [patent_app_number] => 10/582178 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4857 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044819.pdf [firstpage_image] =>[orig_patent_app_number] => 10582178 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582178
Genetic Reference Materials Nov 30, 2004 Abandoned
Array ( [id] => 4933453 [patent_doc_number] => 20080004228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'New Expression Tools for Multiprotein Applications' [patent_app_type] => utility [patent_app_number] => 10/592066 [patent_app_country] => US [patent_app_date] => 2004-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11849 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004228.pdf [firstpage_image] =>[orig_patent_app_number] => 10592066 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/592066
New Expression Tools for Multiprotein Applications Nov 24, 2004 Abandoned
Array ( [id] => 562187 [patent_doc_number] => 07465442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Reduction of dermal scarring' [patent_app_type] => utility [patent_app_number] => 10/997769 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 12575 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465442.pdf [firstpage_image] =>[orig_patent_app_number] => 10997769 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/997769
Reduction of dermal scarring Nov 22, 2004 Issued
Array ( [id] => 5260878 [patent_doc_number] => 20070214511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Transgenic Bird And Method Of Constructing The Same' [patent_app_type] => utility [patent_app_number] => 10/585693 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8667 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20070214511.pdf [firstpage_image] =>[orig_patent_app_number] => 10585693 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/585693
Transgenic Bird And Method Of Constructing The Same Nov 4, 2004 Abandoned
Array ( [id] => 285720 [patent_doc_number] => 07550649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Transgenic non-human mammal' [patent_app_type] => utility [patent_app_number] => 10/577302 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 12269 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550649.pdf [firstpage_image] =>[orig_patent_app_number] => 10577302 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/577302
Transgenic non-human mammal Oct 27, 2004 Issued
Array ( [id] => 5921268 [patent_doc_number] => 20060239966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'In vivo gene therapy of parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 10/520500 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25699 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20060239966.pdf [firstpage_image] =>[orig_patent_app_number] => 10520500 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/520500
In vivo gene therapy of parkinson's disease Oct 19, 2004 Abandoned
Array ( [id] => 7011391 [patent_doc_number] => 20050065107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Plasmids suitable for IL-2 expression' [patent_app_type] => utility [patent_app_number] => 10/965238 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20553 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065107.pdf [firstpage_image] =>[orig_patent_app_number] => 10965238 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/965238
Plasmids suitable for IL-2 expression Oct 14, 2004 Abandoned
Array ( [id] => 5259631 [patent_doc_number] => 20070213263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Methods And Compositions Using Adiponectin For Treatment Of Cardiac Disorders And For Stimulation Of Angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/574828 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14995 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213263.pdf [firstpage_image] =>[orig_patent_app_number] => 10574828 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/574828
Methods And Compositions Using Adiponectin For Treatment Of Cardiac Disorders And For Stimulation Of Angiogenesis Oct 7, 2004 Abandoned
Array ( [id] => 5023503 [patent_doc_number] => 20070149469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Medical use of tbk-1 or of inhibitors thereof' [patent_app_type] => utility [patent_app_number] => 10/574306 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9358 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149469.pdf [firstpage_image] =>[orig_patent_app_number] => 10574306 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/574306
Medical use of tbk-1 or of inhibitors thereof Sep 30, 2004 Abandoned
Array ( [id] => 4949869 [patent_doc_number] => 20080305995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Royal Jelly Peptide and Composition Containing the Same' [patent_app_type] => utility [patent_app_number] => 10/573794 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9821 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305995.pdf [firstpage_image] =>[orig_patent_app_number] => 10573794 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/573794
Royal Jelly Peptide and Composition Containing the Same Sep 26, 2004 Abandoned
Array ( [id] => 7111684 [patent_doc_number] => 20050209140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Methods of controlling axonal growth' [patent_app_type] => utility [patent_app_number] => 10/947994 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14955 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209140.pdf [firstpage_image] =>[orig_patent_app_number] => 10947994 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/947994
Methods of controlling axonal growth Sep 22, 2004 Abandoned
Array ( [id] => 466022 [patent_doc_number] => 07235236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Polynucleotide encoding human adenylylcyclase VI and uses thereof for enhancing cardiac function' [patent_app_type] => utility [patent_app_number] => 10/942072 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33511 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235236.pdf [firstpage_image] =>[orig_patent_app_number] => 10942072 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/942072
Polynucleotide encoding human adenylylcyclase VI and uses thereof for enhancing cardiac function Sep 13, 2004 Issued
Menu